Hat mitgewirkt an:
-
Secreted frizzled related protein 1 (SFRP1) as potential regulator of chemotherapy response and prognostic marker of triple negative breast cancer (TNBC)
-
Influence of secreted frizzled receptor protein 1 (SFRP1) on neoadjuvant chemotherapy in triple negative breast cancer does not rely on WNT signaling